CAH
Price
$153.41
Change
-$3.19 (-2.04%)
Updated
Aug 7 closing price
Capitalization
27.26B
4 days until earnings call
SHTDF
Price
$2.40
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
9.79B
Interact to see
Advertisement

CAH vs SHTDF

Header iconCAH vs SHTDF Comparison
Open Charts CAH vs SHTDFBanner chart's image
Cardinal Health
Price$153.41
Change-$3.19 (-2.04%)
Volume$3.23M
Capitalization27.26B
Sinopharm Group
Price$2.40
Change-$0.00 (-0.00%)
Volume$1K
Capitalization9.79B
CAH vs SHTDF Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. SHTDF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and SHTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CAH: $153.41 vs. SHTDF: $2.40)
Brand notoriety: CAH and SHTDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 163% vs. SHTDF: 77%
Market capitalization -- CAH: $27.26B vs. SHTDF: $9.79B
CAH [@Medical Distributors] is valued at $27.26B. SHTDF’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileSHTDF’s FA Score has 2 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • SHTDF’s FA Score: 2 green, 3 red.
According to our system of comparison, SHTDF is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 2 TA indicator(s) are bullish while SHTDF’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 2 bullish, 7 bearish.
  • SHTDF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SHTDF is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -1.17% price change this week, while SHTDF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.97%. For the same industry, the average monthly price growth was +3.91%, and the average quarterly price growth was +2.30%.

Reported Earning Dates

CAH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Distributors (-0.97% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than SHTDF($9.79B). CAH has higher P/E ratio than SHTDF: CAH (44.47) vs SHTDF (8.00). CAH YTD gains are higher at: 31.147 vs. SHTDF (-3.614). SHTDF has higher annual earnings (EBITDA): 24.7B vs. CAH (1.89B). SHTDF has more cash in the bank: 43.5B vs. CAH (4.59B). CAH has less debt than SHTDF: CAH (4.72B) vs SHTDF (68.4B). SHTDF has higher revenues than CAH: SHTDF (521B) vs CAH (216B).
CAHSHTDFCAH / SHTDF
Capitalization27.3B9.79B279%
EBITDA1.89B24.7B8%
Gain YTD31.147-3.614-862%
P/E Ratio44.478.00556%
Revenue216B521B41%
Total Cash4.59B43.5B11%
Total Debt4.72B68.4B7%
FUNDAMENTALS RATINGS
CAH vs SHTDF: Fundamental Ratings
CAH
SHTDF
OUTLOOK RATING
1..100
5729
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
3100
SMR RATING
1..100
9957
PRICE GROWTH RATING
1..100
4650
P/E GROWTH RATING
1..100
9326
SEASONALITY SCORE
1..100
6590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDF's Valuation (24) in the null industry is somewhat better than the same rating for CAH (62) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is significantly better than the same rating for SHTDF (100) in the null industry. This means that CAH’s stock grew significantly faster than SHTDF’s over the last 12 months.

SHTDF's SMR Rating (57) in the null industry is somewhat better than the same rating for CAH (99) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (46) in the Medical Distributors industry is in the same range as SHTDF (50) in the null industry. This means that CAH’s stock grew similarly to SHTDF’s over the last 12 months.

SHTDF's P/E Growth Rating (26) in the null industry is significantly better than the same rating for CAH (93) in the Medical Distributors industry. This means that SHTDF’s stock grew significantly faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHSHTDF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 5 days ago
49%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
37%
Bullish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 5 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
45%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
51%
Aroon
ODDS (%)
Bearish Trend 1 day ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IFRA50.860.44
+0.87%
iShares US Infrastructure ETF
SPCY30.130.05
+0.17%
STKd 100% SMCI & 100% NVDA ETF
SIXJ32.45-0.01
-0.03%
AllianzIM US Lrg Cp 6M Bfr10 Jan/Jul ETF
JULJ24.99-0.02
-0.06%
Innovator Premium Income 30 Bar ETF -Jul
SBI7.62-0.03
-0.39%
Western Asset Intermediate Muni Fund

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-2.04%
COR - CAH
56%
Loosely correlated
-1.90%
MCK - CAH
52%
Loosely correlated
-5.76%
YI - CAH
14%
Poorly correlated
+0.95%
HSIC - CAH
13%
Poorly correlated
-0.63%
OMI - CAH
12%
Poorly correlated
-1.87%
More

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
N/A
SHTDY - SHTDF
19%
Poorly correlated
-0.32%
COR - SHTDF
17%
Poorly correlated
-1.90%
SHPMY - SHTDF
12%
Poorly correlated
N/A
CAH - SHTDF
12%
Poorly correlated
-2.04%
AHG - SHTDF
10%
Poorly correlated
+6.10%
More